[Media Releases] [E-today] LegoChem attracts venture capital funds (6 Nov 2014)

Title:  LegoChem attracts venture capital funds

Publication: E-today / In-Hyo Kang

Date: 6 Nov 2014

Summary

●      The investment magnate Min-Joo Lee, President of Atinum Partners, is known to invest in LegoChem Biosciences again.

●      InterVest and Korea Investment Partners, which also have paid particular attention to biotech/pharmaceutical industry, are investing in LegoChem along with Atinum.  

●      According to a source, Mr. Lee is seeing that LegoChem’s lucrative oncology pipeline, particularly Antibody-Drug Conjugates (ADCs) proprietary technology will offer a great growth potential.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).